hgr4113
Showing 1 - 1 of 1
Diabetes, Type 2 Trial in Seoul (HGR4113, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- HGR4113
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 30, 2022